Hacein-Bey-Abina S et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415–419.
Lehrman S . Virus treatment questioned after gene therapy death. Nature 1999; 401: 517–518.
Huyghe BG et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther 1995; 6: 1403–1416.
Blanche F et al. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Therapy 2000; 7: 1055–1062.
Shabram PW et al. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 1997; 8: 453–465.
Klyushnichenko V, Bernier A, Kamen A, Harmsen E . Improved high-performance liquid chromatographic method in the analysis of adenoviral particles. J Chromatogr B Biomed Sci Appl 2001; 755: 27–36.
Vellekamp G et al. Empty capsids in column-purified recombinant adenovirus preparations. Hum Gene Ther 2001; 12: 1923–1936.
Adenopure Instruction Manual www.puresyn.com.
Graham FL, Smiley J, Russel WC, Narin R . Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1997; 36: 59–72.
Zhang WW, Koch PE, Roth JA . Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 1995; 18: 444–447.
CAS PubMed Google Scholar
Clark KR, Liu X, McGrath JP, Johnson PR . Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild type viruses. Hum Gene Ther 1999; 10: 1031–1039.
Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973–985.
Auricchio A et al. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther 2001; 12: 71–76.
Brument N et al. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Mol Ther 2002; 6: 678–686.
Green AP et al. A new scalable method for the purification of recombinant adenovirus vectors. Hum Gene Ther 2002; 13: 1921–1934.
McIntyre, 2001-Adenovirus Reference Material Working Group is a consortium of industry, government and academic researchers to manufacture adenovirus reference standards and codify analytical methods under the auspices of the FDA. Information is available at www.wilbio.com.
Zhu J et al. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum Gene Ther 1999; 10: 113–121.
Summerford C, Samulski RJ . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438–1445.
Gao G et al. Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum Gene Ther 2000; 11: 2079–2091.
Smith RH, Ding C, Kotin RM . Serum-free production and column purification of adeno-associated virus type 5. J Virol Methods 2003; 114: 115–124.
Grimm D, Kern A, Rittner K, Kleinschmidt JA . Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum Gene Ther 1998; 9: 2745–2760.
Rabinowitz JE et al. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups. J Virol 2004; 78: 4421–4432.
Kaludov N et al. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 2001; 75: 6884–6893.
Walters RW et al. Binding of adeno-associated virus type 5 to 2, 3-linked sialic acid is required for gene transfer. J Biol Chem 2001; 276: 20610–20616.
Davidoff AM et al. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J Virol Methods 2004; 121: 209–215.
Harris JD, Beattie SG, Dickson JG . Novel tools for production and purification of recombinant adeno-associated viral vectors. Methods Mol Med 2003; 76: 255–267.
CAS PubMed Google Scholar
Maizel Jr JV, White DO, Scharff MD . The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 1968; 36: 126–136.
